
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.08 | 4.7619047619 | 1.68 | 1.7886 | 1.52 | 275340 | 1.59850188 | CS |
4 | 0.05 | 2.92397660819 | 1.71 | 1.7886 | 1.39 | 433734 | 1.59108487 | CS |
12 | -0.28 | -13.7254901961 | 2.04 | 3.49 | 1.39 | 969938 | 2.25073253 | CS |
26 | -1.25 | -41.5282392027 | 3.01 | 3.49 | 1.39 | 638654 | 2.43642485 | CS |
52 | -3.29 | -65.1485148515 | 5.05 | 5.38 | 1.39 | 636247 | 3.10163888 | CS |
156 | -14.96 | -89.4736842105 | 16.72 | 17.28 | 0.359908 | 544544 | 3.38475072 | CS |
260 | -28.24 | -94.1333333333 | 30 | 56.5899 | 0.359908 | 431005 | 8.77277194 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관